Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia

• Main Authors: Vesa Lindström (Author), Janne Aittoniemi (Author), Urpu Salmenniemi (Author), Helena Käyhty (Author), Heini Huhtala (Author), Marjatta Sinisalo (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The 23-valent pneumococcal polysaccharide vaccine (PPV23) given alone is ineffective in patients with chronic lymphocytic leukemia (CLL) and better antibody response is achieved with pneumococcal conjugate vaccines (PCVs). In this study, we determine whether CLL patients would achieve a significant...